SPRINGWORKS THERAPEUTICS, INC. Accounts Receivable
SPRINGWORKS THERAPEUTICS, INC. had Accounts Receivable of $40.35 million as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2025-05-09
- 2025-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $40.35M.
- 2024-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $46.24M.
- 2024-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $32.97M.
- 2024-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $24.50M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2025-03-31 | $40.35M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $46.24M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $32.97M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $24.50M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $15.53M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $5.93M 10-K · filed 2025-02-20 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-27 |